Home  /  Resource Library  /  Outpatient Versus Inpatient Axicabtagene Ciloleucel CAR T-Cell Therapy in Non-Hodgkins Lymphoma: Insights From A US Multicenter Transplant and Cellular Therapy Network

Outpatient Versus Inpatient Axicabtagene Ciloleucel CAR T-Cell Therapy in Non-Hodgkins Lymphoma: Insights From A US Multicenter Transplant and Cellular Therapy Network

Stkudy examined outpatient versus inpatient treatment of CAR-T axicabtagene ciloleucel for DLBCL.